Pharmafile Logo
Pharmafocus logo
Advanced Search

Roche

Showing 15 posts of 710 posts found.

Roche

Roche and Evotec to collaborate on cancer biomarkers

June 24, 2011
Research and Development Evotec, Roche, biomarkers

Roche and Evotec are to collaborate to find biomarkers for Roche oncology drugs under development. Roche has been one of …

News
Roche

Roche launches R&D Institute in France

June 24, 2011
Research and Development Roche, translational research

Roche has launched a new R&D Institute in France, furthering its links with academic centres in the country. The Institute, …

News
rocheroof

Mid-stage trial boost for Roche skin cancer drug vismodegib

June 20, 2011
Research and Development Cancer, Roche, skin cancer, vismodegib

Roche’s novel skin cancer drug vismodegib has met its primary endpoint in a phase II trial. Vismodegib is an investigational, …

News

Roche and Merck collaborate on personalised cancer tests

June 8, 2011
Research and Development Merck, Roche, personalised medicine

Roche has signed a deal to develop diagnostic tests for products in Merck’s oncology pipeline, in a bid to make …

News
Roche

Roche impresses at ASCO with vemurafenib

June 6, 2011
Research and Development, Sales and Marketing ASCO, Roche, skin cancer, vemurafenib

Roche’s vemurafenib has proven one of the stars of the ASCO cancer conference by increasing overall survival in skin cancer …

News

BMS and Roche to team up in melanoma

June 3, 2011
Sales and Marketing BMS, Roche, melanoma, oncology

Bristol-Myers Squibb and Roche are to use two of their drugs in an exploratory phase I/II study a bid to …

News

Tarceva impresses again as it seeks to extend its EU licence

June 3, 2011
NSCLC, Roche, Tarceva

Roche and its partner OSI Pharmaceuticals have released another series of positive results for its lung cancer drug Tarceva as …

News
Blog footer

Digital Pharma: Roche launches online warfarin training for patients

May 27, 2011
Medical Communications Digital Pharma blog, Roche, anticoagulant, warfarin

Roche has launched an online training tool to help UK patients on long-term warfarin learn about anticoagulation self-monitoring. The CoaguChek …

News
Roche's MabThera’s (rituximab)

NICE U-turn on Roche’s MabThera

May 25, 2011
Sales and Marketing MabThera, NICE, Roche

NICE has provisionally recommended Roche’s MabThera as a maintenance therapy for blood cancer patients. The new draft guidance backs MabThera’s …

News
Roche

MetMab produces exciting results in lung cancer patients

May 19, 2011
Research and Development MetMAb, Roche

Roche’s MetMab has shown huge promise in phase II trials in lung cancer – but only in patients with ‘high …

News
Merck & Co's Victrelis (boceprevir)

Merck and Roche sign hepatitis C co-promotion deal

May 18, 2011
Medical Communications, Sales and Marketing Merck, Roche, hepatitis C

Merck & Co and Roche have signed an agreement that will see them co-promote each other’s hepatitis C drugs in …

News
Roche

Roche aims for wholly personalised skin cancer drug

May 12, 2011
Sales and Marketing Roche, personalised medicine, skin cancer, vemurafenib

Roche has submitted its key skin cancer drug vemurafenib to European and American regulators for approval. Vemurafenib (formerly RG7204) has …

News
roche

Roche growth stalls after Avastin setback

April 14, 2011
Research and Development, Sales and Marketing Roche

Revenues at Roche flattened out in the first three months of 2011, as Avastin sales declined in the US and Europe. Group …

News
Roche

Roche changes raise Novartis takeover question

March 29, 2011
Sales and Marketing Novartis, Roche, mergers and acquisitions

Roche could be vulnerable to a takeover from its Swiss rival Novartis after changes in its boardroom. The Roche family …

News
Roche's Swiss headquarters

Roche’s skin cancer drug passes mid-stage trial

March 22, 2011
Research and Development Curis, Roche, advanced basal cell carcinoma, skin cancer, vismodegib

Roche’s skin cancer candidate vismodegib has met its primary endpoint in a phase II trial. The drug is being tested …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025